Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
Abstract
Prostate-specific membrane antigen (PSMA) imaging has been suggested as highly sensitive modality for detection of metastases in patients with biochemically recurrent or advanced prostate cancer (PCa). PSMA expression is associated with grade and stage and has a relationship with androgen receptor signaling. The aim of this study was to evaluate the prognostic utility of radiographic PSMA expression in men with metastatic castration-resistant prostate cancer (mCRPC).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 18, 2021
- Source ID
- 10.3389/fonc.2021.630589
Entities
People
- Ana M. Molina
- Charlene Thomas
- David M. Nanus
- Joseph R. Osborne
- Michael Sun
- Muhammad Junaid Niaz
- Neil H Bander
- Panagiotis J Vlachostergios
- Paul J. Christos
- Scott T Tagawa
- Seyed Ali Mosallaie
Organizations
- National Institutes of Health
- Prostate Cancer Foundation
- United States Department of Defense